Skip to content
← Full study record

NCT03113500 · MORE INFO

Limitations, agreements, and source contact

Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma · Source last updated 2026-08-21

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
aherrera@coh.org
organization
City of Hope Medical Center
phone
626-359-8111
title
Dr. Alex Herrera
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
aherrera@coh.org
organization
City of Hope Medical Center
phone
626-359-8111
title
Dr. Alex Herrera

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice